In Stock
CNS clinical trials
Paperback
€42.00
Collect 126 Reward Points
- Free Delivery from
- This Book Is Available Online Only
- Book Synopsis
- The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system-including psychiatric drugs-are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future.
- Product Details
-
- ISBN
- 9780309148832
- Format
- Paperback
- Publisher
- The National Academies Press, (22 December 2010)
- Number of Pages
- 75
- Language
- English
- Dimensions
- 229 x 152 mm
- Categories: